ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed

Kristina Jansen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5039217643. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 2 papers

Papers 2

Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. Last author DOI 10.1080/07357907.2021.1943747 ↗
DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. Co-author DOI 10.7717/peerj.11905 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Till Krech · 2 shared papers, 2021 · strength 0.20
- Paper Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. DOI 10.1080/07357907.2021.1943747 ↗
- Paper DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. DOI 10.7717/peerj.11905 ↗
Till Sebastian Clauditz · 2 shared papers, 2021 · strength 0.20
- Paper Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. DOI 10.1080/07357907.2021.1943747 ↗
- Paper DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. DOI 10.7717/peerj.11905 ↗
Jakob Robert Izbicki · 2 shared papers, 2021 · strength 0.20
- Paper Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. DOI 10.1080/07357907.2021.1943747 ↗
- Paper DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. DOI 10.7717/peerj.11905 ↗
Sören Alexander Weidemann · 1 shared paper, 2021 · strength 0.11
- Paper Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. DOI 10.1080/07357907.2021.1943747 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.